Skip to content

Understanding chronic cough

Comparing Capsaicin Dose-Response Curves

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN65122210
Enrollment
60
Registered
2011-04-07
Start date
2009-11-01
Completion date
Unknown
Last updated
2017-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic cough Respiratory Chronic cough

Interventions

Two capsaicin cough challenge tests performed: 1. Increasing doses are inhaled up to maximum tolerated dose 2. Doses are inhaled in a random order 3. Number of coughs and urge-to-cough intensity recor

Sponsors

University Hospitals South Manchester NHS Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy volunteers 1. Over 18 years old 2. Normal lung function 3. No current or past history of chronic cough or chronic respiratory illness 4. No current or past history of chronic pain, irritable bowel syndrome or chronic headaches 5. No current or past history of psychiatric illness Asthmatics 1. Over 18 years old 2. Physician diagnosis of asthma 3. Objective evidence of bronchial hyper-reactivity (either positive bronchial provocation test or significant (>12%) reversibility in FEV1 following inhaled bronchodilator) 4. Stable asthma [forced expiratory volume in one second (FEV1) > 75% predicted, no acute exacerbations requiring oral corticosteroids within last 4 weeks] 5. Can safely omit long-acting bronchodilators (if taking) Chronic Cough Patients 1. Over 18 years old 2. Chronic cough, defined as a cough lasting longer than 8 weeks despite investigation and/or treatment trials for cough variant asthma, post-nasal drip and gastro-oesophageal reflux disease 3. Normal chest x-ray 4. Normal lung function 5. Can safely omit long-acting bronchodilators (if taking)

Exclusion criteria

Exclusion criteria: All participants: 1. Recent upper respiratory tract infection ( 10 pack year smoking history

Design outcomes

Primary

MeasureTime frame
Comparison of maximum cough responses between patient groups

Secondary

MeasureTime frame
1. Comparison of cough threshold between patient groups 2. Comparison of urge-to-cough threshold between patient groups 3. Comparison of maximum cough responses and cough threshold in men and women

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026